Raising Health
AI in Pharmaceutical R&D with Kim Branson
May 14, 2024
Kim Branson, SVP and Global Head of AI and Machine Learning for GSK, discusses how AI has revolutionized drug discovery and development, highlighting its applications in the lab. They also delve into the criteria for an ideal biopharma partner and the allure of innovative solutions in the biotech AI space.
31:15
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- AI has revolutionized drug discovery through advanced measurement technologies and machine learning.
- Pharmaceutical companies are evolving into immune programming entities, leveraging AI software for accurate patient response predictions.
Deep dives
AI's Impact on Drug Discovery and Development
AI has significantly improved drug discovery by utilizing cheap and advanced measurement technologies like sequencing and RNA-seq. With the increasing amount of data, machine learning has become essential in analyzing and making sense of this information. The podcast discusses how AI can be deployed in the lab to enhance drug discovery processes, highlighting the vital role of new measurement technologies and machine learning in advancing medicine.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
